Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Supportive Care in Cancer
Published in: Supportive Care in Cancer 10/2012

01-10-2012 | Original Article

Validation of the Chinese version of Multidimensional Fatigue Inventory-20 in Chinese patients with cancer

Authors: Jun Tian, Jin-Sheng Hong

Published in: Supportive Care in Cancer | Issue 10/2012

Login to get access

Abstract

Goals of work

The purpose of this research is to study the validation of the Chinese version of Multidimensional Fatigue Inventory-20 in measuring fatigue status of the patients with cancer in China.

Materials and methods

The original English version of the Multidimensional Fatigue Inventory-20 was translated into a Chinese version, which was applied to measure the fatigue status of cancer patients prior to commencing chemotherapy and during the last week of chemotherapy, respectively. The reliability and criterion-related validity of the Chinese version of the Multidimensional Fatigue Inventory-20 were assessed by calculating Cronbach's α and Pearson correlation coefficients. The construct validity was analyzed by employing factor analysis.

Main results

There were three dimensions in the Chinese version of the MFI-20, which measures the physical, mental, and spiritual fatigue of patients with cancer. All of the correlation coefficients between EORTC QLQ-C30V3.0 and MFI-20 were statistically significant (P < 0.0001). The Cronbach's α coefficient was more than 0.8 and 0.7 for total MFI-20 and for the three dimensions of the Chinese version of the MFI-20, respectively.

Conclusions

The Chinese version of the MFI-20 is a reliable and valid instrument to assess fatigue in Chinese patients with cancer.
Literature
1.
Winningham ML, Nail LM, Burke MB et al (1994) Fatigue and the cancer experience: the state of the knowledge. Oncol Nurs Forum 21(1):23–36PubMed
2.
Giacalone A, Polesel J, Paoli AD et al (2010) Assessing cancer-related fatigue: the psychometric properties of the Revised Piper Fatigue Scale in Italian cancer inpatients. Support Care Cancer 18:1191–1197PubMedCrossRef
3.
Haghighat S, Akbari ME, Holakouei K et al (2003) Factors predicting fatigue in breast cancer patients. Support Care Cancer 11(8):533–538PubMedCrossRef
4.
Romito F, Montanaro R, Corvasce C et al (2008) Is cancer-related fatigue more strongly correlated to haematological or to psychological factors in cancer patients? Support Care Cancer 16(8):943–946PubMedCrossRef
5.
Curt GA, Breitbart W et al (2000) Impact of cancerrelated fatigue on the lives of patients: new findings from the Fatigue Coalition. Oncologist 5:353–360PubMedCrossRef
6.
Chang YJ, Lee JS, Lee CG et al (2007) Assessment of clinical relevant fatigue level in cancer. Support Care Cancer 15(7):891–896PubMedCrossRef
7.
Piper BF, Lindsey AM, Dodd MJ (1987) Fatigue mechanism in cancer patients: developing nursing theory. Oncol Nurs Forum 14:17–23PubMed
8.
Smets EM, Garssen B, Bonke B, De Haes JC (1995) The Multidimensional Fatigue Inventory (MFI) psychometric qualities of an instrument to assess fatigue. J Psychosom Res 39:315–325PubMedCrossRef
9.
Hagelin CL, Wengström Y, Runesdotter S, Fürst CJ (2007) The psychometric properties of the Swedish Multidimensional Fatigue Inventory MFI-20 in four different population. Acta Oncol 46:97–104PubMedCrossRef
10.
Smets EM, Garssen B, Cull A, De Haes JC (1996) Application of the multidimensional fatigue inventory (MFI-20) in cancer patients receiving radiotherapy. Br J Cancer 73:241–245PubMedCrossRef
11.
Aronson NK, Cull A, Keasa S et al (1994) The European Organization for Research and Treatment of Cancer (EORTC) modular approach to quality of life assessment in oncology. Int J Ment Health 23(2):75–96
12.
Zhen LC, Tian HR, Xie PZ (2000) Medical quality of survival evaluation. Junshi Yixue Kexue Press, Beijing
13.
Nunnally JM, Bernstein IH (1994) Psychometric theory, 3rd edn. McGraw-Hill, New York
14.
Schneider RA (1998) Reliability and validity of the Multidimensional Fatigue Inventory (MFI-20) and the Rhoten Fatigue Scale among rural cancer outpatients. Cancer Nurs 21(5):370–373PubMedCrossRef
15.
Gentile S, Delarozière JC, Favre F, Sambuc R, San Marco JL (2003) Validation of the French ‘multidimensional fatigue inventory’ (MFI 20). Eur J Cancer Care 12:58–64CrossRef
16.
Hagelin CL, Wengström Y, Fürst CJ (2009) Patterns of fatigue related to advanced disease and radiotherapy in patients with cancer—a comparative cross-sectional study of fatigue intensity and characteristics. Support Care Cancer 17:519–526CrossRef
17.
Kuhnt S, Ernst J, Singer S, Rüffer JU, Kortmann R-D, Stolzenburg J, Schwarz R (2009) Fatigue in cancer survivors—prevalence and correlates. Onkologie 32:312–317PubMedCrossRef
18.
Munch TN, Strömgren AS, Pedersen L, Petersen MA, Hoermann L, Groenvold M (2006) Multidimensional measurement of fatigue in advanced cancer patients in palliative care: an application of the Multidimensional Fatigue Inventory. J Pain Symptom Manage 31(6):533–541PubMedCrossRef
19.
Lundh HC, Wengström Y, Runesdotter S, Fűrst CJ (2007) The psychometric properties of the Swedish Multidimensional Fatigue Inventory MFI-20 in four different populations. Acta Oncol 46:97–104CrossRef
Metadata
Title
Validation of the Chinese version of Multidimensional Fatigue Inventory-20 in Chinese patients with cancer
Authors
Jun Tian
Jin-Sheng Hong
Publication date
01-10-2012
Publisher
Springer-Verlag
Published in
Supportive Care in Cancer / Issue 10/2012
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-011-1357-8

Other articles of this Issue 10/2012

Supportive Care in Cancer 10/2012 Go to the issue

Original Article

A pilot study to examine patient awareness and provider discussion of the impact of cancer treatment on fertility in a registry-based sample of African American women with breast cancer

Original Article

Chore or priority? Barriers and facilitators affecting dilator use after pelvic radiotherapy for gynaecological cancer

Original Article

Cardiac effects of granisetron in a prospective crossover randomized dose comparison trial

Original Article

Preferred place of care and place of death of the general public and cancer patients in Japan

Short Communication

Efficacy and safety of palonosetron as salvage treatment in the prevention of chemotherapy-induced nausea and vomiting in patients receiving low emetogenic chemotherapy (LEC)

Original Article

Health-related quality of life in high-grade glioma patients: a prospective single-center study
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits